1型糖尿病中的自身免疫CD8+T细胞:从单细胞RNA测序到T细胞受体重定向

Kangping Yang1, Yihan Zhang2, Jiatong Ding2

  • 1Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

PubMed
概括

针对自身免疫性CD8+T细胞及其T细胞受体 (TCRs) 显示出治疗1型糖尿病 (T1D) 的前景. 了解这些细胞和CAR-T和TCR-T等先进疗法是T1D预测和治疗的关键.